Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey

doi:10.12998/wjcc.v11.i20.4865

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 20

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4372)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

123

WORD

HTML

1792

Tables (1-4)

584

Sum=2546

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

303

Download

1338

Sum=1641

Jul 16, 2023 (publication date) through Mar 2, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Cases. Jul 16, 2023; 11(20): 4865-4873
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4865

Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey

Ozlem Celik Aydin, Sonay Aydin, Hakkı Zafer Guney

Ozlem Celik Aydin, Sonay Aydin, Hakkı Zafer Guney, Department of Medical Pharmacology, Gazi University Faculty of Medicine, Ankara 06500, Turkey

Author contributions: Aydin OC and Guney HZ put forward the concept; Aydin OC was responsible for designing; Guney HZ were responsible for supervision; Aydin S, Aydin OC and Guney HZ did the literature search and reviewed the manuscript critically; Aydin S and Aydin OC were responsible for materials and wrote the manuscript; All authors have read and approved the final manuscript.

Institutional review board statement: This cross-sectional analytical investigation was approved by the Gazi University Clinical Research Ethics Committee, No. 25901600-604.01.01-16.

Informed consent statement: The study included everyone who agreed to participate in the survey.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: All data will be shared with the relevant parties upon request atozlemclk_89@hotmail.com.

CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.

Corresponding author: Ozlem Celik Aydin, MD, Doctor, Department of Medical Pharmacology, Gazi University Faculty of Medicine, Besevler, Ankara 06500, Turkey. ozlemclk_89@hotmail.com

Received: February 21, 2023
Peer-review started: February 21, 2023
First decision: April 10, 2023
Revised: May 1, 2023
Accepted: June 9, 2023
Article in press: June 9, 2023
Published online: July 16, 2023
Processing time: 140 Days and 11.5 Hours

Abstract

BACKGROUND

Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems.

AIM

To define the awareness and experiences of the clinicians on PV and adverse drug reactions (ADRs) in Turkey.

METHODS

The study was cross-sectional and analytical. Data were obtained through a questionnaire. The questionnaire was sent via e-mail. The survey was sent to 2030 physicians and 670 participated.

RESULTS

The most appropriate definition of PV was correctly defined by 53.9% of the participants. The most important goal of PV was correctly defined by 54.9% of the participants, and 27.3% of the participants were aware of the Turkish Pharmacovigilance Center. Nonsurgical physicians had better PV knowledge than surgical physicians. A total of 80.9% of the physicians who encountered ADRs, filled in the ADR notification form, and 8.8% received training on how to fill in the form. PV knowledge of the clinicians was not sufficient. Although half of the physicians encountered ADRs, the rates of seeing and filling in the ADR form were low.

CONCLUSION

Few of the physicians followed the current information about PV. The results provide more comprehensive data on PV practices and ADR reporting at a national level.

Keywords: Pharmacovigilance; Physicians; Knowledge level; Attitude; Behavior; Adverse drug reaction

Core tip: Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems. This study define the awareness and experiences of clinicians about PV and adverse drug reactions (ADRs) in Turkey. PV knowledge level of the physicians was not sufficient. The results provide more comprehensive data on PV practices and ADR reporting at a national level.